PM

Prosight Management Portfolio holdings

AUM $410M
1-Year Return 14.96%
This Quarter Return
-22.55%
1 Year Return
-14.96%
3 Year Return
+21.81%
5 Year Return
+1.17%
10 Year Return
AUM
$194M
AUM Growth
+$17.3M
Cap. Flow
+$58M
Cap. Flow %
29.92%
Top 10 Hldgs %
60.4%
Holding
41
New
9
Increased
19
Reduced
7
Closed
5
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
EOLS icon
26
Evolus
EOLS
$473M
$2.33M 1.2%
195,911
+57,451
+41% +$684K
TPST icon
27
Tempest Therapeutics
TPST
$44.4M
$2.04M 1.05%
1,317
+794
+152% +$1.23M
LGND icon
28
Ligand Pharmaceuticals
LGND
$3.26B
$1.71M 0.88%
+20,198
New +$1.71M
GTS
29
DELISTED
Triple-S Management Corporation
GTS
$1.14M 0.59%
+68,863
New +$1.14M
CLVS
30
DELISTED
Clovis Oncology, Inc.
CLVS
$1.08M 0.56%
+60,100
New +$1.08M
AVTX icon
31
Avalo Therapeutics
AVTX
$135M
$994K 0.51%
+107
New +$994K
PVLA
32
Palvella Therapeutics, Inc. Common Stock
PVLA
$578M
$885K 0.46%
4,161
-16,613
-80% -$3.53M
OPTN
33
DELISTED
OptiNose
OPTN
$870K 0.45%
+9,354
New +$870K
CDTX icon
34
Cidara Therapeutics
CDTX
$1.64B
$578K 0.3%
12,288
-3,957
-24% -$186K
NGNE icon
35
Neurogene
NGNE
$281M
$173K 0.09%
4,014
+1,181
+42% +$50.9K
KZR icon
36
Kezar Life Sciences
KZR
$28.2M
-5,233
Closed -$1.12M
MGTX icon
37
MeiraGTx Holdings
MGTX
$612M
-38,746
Closed -$527K
TVTX icon
38
Travere Therapeutics
TVTX
$1.81B
0
EIGR
39
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
-11,382
Closed -$4.1M
NVLN
40
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
-444,068
Closed -$1.31M
SHPG
41
DELISTED
Shire pic
SHPG
-23,400
Closed -$4.24M